TIAA Trust National Association Has $3.35 Million Stake in Lam Research Corporation $LRCX

TIAA Trust National Association raised its holdings in Lam Research Corporation (NASDAQ:LRCX) by 2.0% in the second quarter, Holdings Channel reports. The fund owned 34,414 shares of the semiconductor company’s stock after acquiring an additional 691 shares during the period. TIAA Trust National Association’s holdings in Lam Research were worth $3,350,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in LRCX. Vanguard Group Inc. grew its stake in Lam Research by 6.9% in the first quarter. Vanguard Group Inc. now owns 129,152,102 shares of the semiconductor company’s stock valued at $9,389,358,000 after acquiring an additional 8,364,375 shares during the period. Nuveen LLC acquired a new position in Lam Research in the first quarter valued at about $604,344,000. Price T Rowe Associates Inc. MD grew its stake in Lam Research by 99.7% in the first quarter. Price T Rowe Associates Inc. MD now owns 5,739,221 shares of the semiconductor company’s stock valued at $417,242,000 after acquiring an additional 2,864,863 shares during the period. Nordea Investment Management AB grew its stake in Lam Research by 34.1% in the second quarter. Nordea Investment Management AB now owns 10,594,574 shares of the semiconductor company’s stock valued at $1,029,210,000 after acquiring an additional 2,692,189 shares during the period. Finally, Boston Partners grew its stake in Lam Research by 9,978.3% in the first quarter. Boston Partners now owns 2,350,362 shares of the semiconductor company’s stock valued at $170,787,000 after acquiring an additional 2,327,041 shares during the period. 84.61% of the stock is owned by institutional investors and hedge funds.

Lam Research Stock Performance

LRCX opened at $161.24 on Tuesday. Lam Research Corporation has a 52-week low of $56.32 and a 52-week high of $165.22. The firm has a market capitalization of $202.52 billion, a PE ratio of 35.52, a PEG ratio of 1.68 and a beta of 1.84. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.60 and a current ratio of 2.21. The business’s 50-day simple moving average is $130.33 and its 200 day simple moving average is $104.18.

Lam Research (NASDAQ:LRCX) last released its earnings results on Wednesday, October 22nd. The semiconductor company reported $1.26 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.22 by $0.04. Lam Research had a return on equity of 60.60% and a net margin of 29.66%.The business had revenue of $5.32 billion for the quarter, compared to analyst estimates of $5.23 billion. During the same quarter in the prior year, the company posted $0.86 earnings per share. Lam Research’s revenue was up 27.7% on a year-over-year basis. Lam Research has set its Q2 2026 guidance at 1.050-1.250 EPS. As a group, sell-side analysts expect that Lam Research Corporation will post 3.71 earnings per share for the current fiscal year.

Lam Research Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Wednesday, October 15th. Investors of record on Wednesday, September 24th were issued a dividend of $0.26 per share. The ex-dividend date was Wednesday, September 24th. This is a boost from Lam Research’s previous quarterly dividend of $0.23. This represents a $1.04 annualized dividend and a yield of 0.6%. Lam Research’s dividend payout ratio is currently 22.91%.

Analyst Upgrades and Downgrades

LRCX has been the subject of several recent research reports. BNP Paribas Exane upped their price objective on Lam Research from $80.00 to $140.00 and gave the stock a “neutral” rating in a research report on Thursday, October 23rd. The Goldman Sachs Group upped their price objective on Lam Research from $115.00 to $160.00 and gave the stock a “buy” rating in a research report on Wednesday, October 8th. Raymond James Financial upped their price objective on Lam Research from $90.00 to $110.00 and gave the stock an “outperform” rating in a research report on Thursday, July 31st. Cowen reaffirmed a “buy” rating on shares of Lam Research in a research report on Thursday, October 23rd. Finally, Mizuho upped their price objective on Lam Research from $162.00 to $170.00 and gave the stock an “outperform” rating in a research report on Thursday, October 23rd. One analyst has rated the stock with a Strong Buy rating, twenty-six have given a Buy rating and nine have given a Hold rating to the stock. According to MarketBeat.com, Lam Research currently has a consensus rating of “Moderate Buy” and a consensus price target of $148.54.

Insider Activity

In other Lam Research news, SVP Vahid Vahedi sold 52,190 shares of the company’s stock in a transaction that occurred on Monday, October 13th. The stock was sold at an average price of $138.90, for a total value of $7,249,191.00. Following the sale, the senior vice president owned 251,047 shares in the company, valued at $34,870,428.30. This represents a 17.21% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, insider Ava Harter sold 9,010 shares of the company’s stock in a transaction that occurred on Monday, October 27th. The shares were sold at an average price of $157.47, for a total value of $1,418,804.70. Following the completion of the sale, the insider owned 56,786 shares in the company, valued at $8,942,091.42. This represents a 13.69% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Corporate insiders own 0.31% of the company’s stock.

Lam Research Company Profile

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.